Assessing perinatal hepatitis B screening and neonatal prophylaxis in a large, multiethnic county

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 2, 2006, Pages 101-108

  González Quintero, Víctor Hugo ^a   Katz, Dolly ^b   Pandya Smith, Indra ^b   Tolaymat, Lama ^b   O'Sullivan, Mary Jo ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Hepatitis B vaccine; Hepatitis B virus; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL POLICY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PERINATAL PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; VACCINATION;

ANALYSIS OF VARIANCE; COHORT STUDIES; CONFIDENCE INTERVALS; ETHNIC GROUPS; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; INFANT, NEWBORN; LOGISTIC MODELS; NEONATAL SCREENING; PERINATAL CARE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VACCINATION;

EID: 33244488300     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morbid Mortal Wkly Rep 1991;40:1-19
2. Beasley PR, Hwang L-Y: Epidemiology of hepatocellular carcinoma. In Viral Hepatitis and Liver Disease. Edited by GN Vyas, JL Dienstag, JH Hoofnagle. New York, Grune & Stratton, 1984, pp 209-224
3. Maternal hepatitis B screening practices-California, Connecticut, Kansas, and United States, 1992-1993. MMWR Morbid Mortal Wkly Rep 1994;43:311-320
4. Barr D, Hershow R, Furner S, et al: Assessing prenatal hepatitis B screening in Illinois with an inexpensive study design adaptable to other jurisdictions. Am J Pub Health 1999;89:19-24
5. Pierce RL, Smith S, Rowe-West B, et al: Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina. Arch Pediatr Adolesc Med 1999;153:619-623
6. Biroscak BJ, Fiore AE, Fasano N, et al: Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan. Pediatrics 2003;111:645-649
7. Clark SJ, Cabana MD, Malik T, et al: Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations. Arch Pediatr Adolesc Med 2001;155:915-920
8. Oram RJ, Daum RS, Seal JB, et al: Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. JAMA 2001;285:1874-1879
9. Hurie MB, Saari TN, Davis JP: Impact of the joint statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices. Pediatrics 2001;107:755-758
10. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices. MMWR Morbid Mortal Wkly Rep 2001;50:94-97
11. Notice to readers: Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morbid Mortal Wkly Rep 1999;48:563-565
12. Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR Morbid Mortal Wkly Rep 1999;48:780-782
13. Thomas AR, Fiore AE, Corwith HL, et al: Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: Effects of the Joint Statement on Thimerosal in Vaccines. Pediatr Infect Dis J 2004;23:313-318
14. US Census Bureau, http://quickfacts.census.lgov/qfd/states/12/12086.html
15. Notice to readers: FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined (PEDIARIX™), for use in infants. MMWR Morbid Mortal Wkly Rep 2003;52:203-204
16. FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis (recombinant) combined vaccine. MMWR Morbid Mortal Wkly Rep 1997;46:107-109
17. Combination vaccines for childhood immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR Morbid Mortal Wkly Rep 1999;48:1-15
18. Cooper A, Yusuf H, Rodewald L, et al: Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth. Pediatrics 2001;108:98-104
19. Euler GL, Wooten KG, Baughman AL, et al: Hepatitis B surface antigen prevalence among pregnant women in urban areas: Implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003;111:1192-1197